Acute Type A Aortic Dissection Complicated by COVID-19 Infection
This report shows the feasibility for surgical treatment of acute aortic disease in patients with COVID-19.
Acute Pulmonary Embolism in SARS-CoV-2 Infection Treated With Surgical Embolectomy
We report a case of SARS-CoV-2 complicated by a massive pulmonary embolism in a patient who underwent successful surgical embolectomy.
Surgical Revascularization With Cardiopulmonary Bypass on a Patient With Severe COVID-19
In this article, we describe the case of a diabetic patient with COVID-19 and a concomitant 3-vessel disease with a formal indication for surgical revascularization, who unexpectedly presented with a high heparin resistance during cardiopulmonary bypass.
Cardiothoracic Surgery During COVID-19: Our Experience with Different Strategies
All asymptomatic patients should be tested for COVID-19 using RT-PCR prior to cardio-thoracic surgeries not only to contain the disease but to avoid potential implications of COVID-19 on the perioperative course, without added financial implications.
COVID-19: Scientific Reasoning, Pragmatism and Emotional Bias
We are left with the same conclusion: to prove and disprove something is the basis of scientific progress. It is possible, then, that future data will disprove the non-existence of spontaneously induced lung injury or prove the tragic consequences of ignoring it.
COVID-19 Safety: Aerosol-Generating Procedures and Cardiothoracic Surgery and Anaesthesia – Australian And New Zealand Consensus Statement
This statement reflects changes in management based on expert opinion, national guidelines and available evidence. Our knowledge with regard to COVID‐19 continues to evolve and with this, guidance may change and develop. Our colleagues are urged to follow national guidelines and institutional recommendations regarding best practices to protect their patients and themselves.
Minimally Invasive Cardiac Valve Surgery During The COVID-19 Pandemic: To Do or Not To Do, That Is The Question
During these unprecedented times, due to factors related to staff, experience, equipment and potential infection, we herein reflect if we should be doing MICS.
Extracorporeal Membrane Oxygenation For COVID-19 Induced Hypoxia: Single-Center Study
ECMO is a supportive intervention for COVID-19 associated pneumonia that could be considered if the optimum mechanical ventilation is deemed ineffective.
Covid19 Acute Respiratory Distress Syndrome and Extra-Corporeal Membrane Oxygenation; A Mere Option or Ultimate Necessity
Herein, we chronicle a review encompassing the available evidence on ECMO and its potential role in COVID19 ARDS, as we aim for optimal patient care with appropriate resource utilization and conservation.
A Nationwide Survey of Uk Cardiac Surgeons’ View on Clinical Decision Making During the Coronavirus Disease 2019 (Covid-19) Pandemic
In this unprecedented pandemic period, this survey provides information for generating interim recommendations until data from clinical observations become available.
Extracorporeal Membrane Oxygenation Support In COVID-19: An International Cohort Study of The Extracorporeal Life Support Organization Registry
In patients with COVID-19 who received ECMO, both estimated mortality 90 days after ECMO and mortality in those with a final disposition of death or discharge were less than 40%. These data from 213 hospitals worldwide provide a generalisable estimate of ECMO mortality in the setting of COVID-19.
COVID-19: FAQs in Pediatric Cardiac Surgery—A Sequel
Our knowledge of the COVID-19 pandemic continues to grow rapidly, leading to further clarity and revealing new questions in turn, thus it is critically important that clinician knowledge is updated frequently.